News

Filter

Current filters:

IsentressNorth America

Merck gains expanded Isentress indication; lowers price of drug for ADAps

23-12-2011

In two pieces of HIV/AIDS-related news for US drugs giant Merck & Co (NYSE: MRK), the company’s…

Anti-viralsIsentressMerck & CoNorth AmericaPharmaceuticalPricingRegulation

Merck slammed over drug pricing

12-12-2011

In another swipe at US pharma giant Merck & Co (NYSE: MRK), the AIDS Healthcare Foundation (AHF) has…

Anti-viralsIsentressMerck & CoNorth AmericaPharmaceuticalPricing

AHF takes campaign to Merck & Co’s home town with AIDS banners protesting high cost of Isentress

17-02-2010

As part of its ongoing campaign to lower AIDS drug prices and increase access, the USA-based AIDS Healthcare…

Anti-viralsIsentressMerck KGaANorth AmericaPharmaceuticalPoliticsPricingRaltegravir Tablets

AIDS Healthcare Foundation bans Merck & Co’s drug reps from its clinics

27-01-2010

The AIDS Healthcare Foundation (AHF), the largest global AIDS organization which operates free AIDS treatment…

Anti-viralsIsentressMerck KGaANorth AmericaPharmaceuticalPricingRaltegravir Tablets

Positive Ph III findings for Merck & Co’s HIV/AIDS drug Isentress

11-08-2009

The online edition of The Lancet has published results from a 48-week Phase III study of treatment-naive…

EfavirenzEmtricitabineEmtrivaImmunologicalsIsentressMerck KGaANorth AmericaPharmaceuticalRaltegravir TabletsSustiva

Back to top